Home/Pipeline/Clostridium difficile Research Components & Diagnostics

Clostridium difficile Research Components & Diagnostics

Clostridium difficile Infection (Research & Diagnostics)

CommercialActive

Key Facts

Indication
Clostridium difficile Infection (Research & Diagnostics)
Phase
Commercial
Status
Active
Company

About TGC Biomics

tgcBIOMICS is a Berlin-based biotechnology service and product company with deep expertise in microbiology and genetic engineering. It operates a hybrid business model, providing contract research and development (CRO-like services) while also commercializing its own proprietary research tools and diagnostic kits, primarily focused on Clostridium difficile. The company leverages its founders' academic pedigree in microbiology to serve research and diagnostic development markets, positioning itself as a specialized partner for complex protein production and infectious disease research. Its activities are supported by participation in EU-funded research projects, indicating collaborative innovation.

View full company profile

Therapeutic Areas